Literature DB >> 8245507

Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics.

M Hertl1, H Bohlen, F Jugert, C Boecker, R Knaup, H F Merk.   

Abstract

The phenotype and functional characteristics of skin-infiltrating lymphocytes in beta-lactam antibiotic-induced vesiculobullous exanthemas were studied in vivo and in vitro. Immunohistochemical analysis demonstrated that CD8+ T lymphocytes were the predominant epidermal T-cell subset in these reactions. Epidermal T lymphocytes were isolated and expanded for in vitro studies. Fluorescence-activated cell sorter analysis showed the majority of epidermal T cells to be CD3+, T-cell receptor alpha/beta+, CD4-, CD8+, and HLA-DR+, which correlated with the predominance of epidermal CD8+ T lymphocytes found in situ. Three CD8+ epidermal T-cell clones derived from cutaneous lesions proliferated in response to penicillin-pulsed autologous antigen-presenting cells but not allogeneic antigen-presenting cells, indicating that those clones were antigen and major histocompatibility complex specific. All T-cell clones produced significant amounts of interleukin-2, interferon-gamma, and granulocyte-macrophage colony-stimulating factor. Additionally, the T-cell clones displayed cytotoxicity against epidermal cells in lectin-mediated cytotoxicity and against B-cell lines in T-cell receptor-triggered cytotoxicity. These data demonstrate the presence of epidermal drug-specific CD8+ T cells in bullous drug reactions. Because these CD8+ T cells have a cytotoxic potential, they may contribute to the necrosis of keratinocytes associated with drug-induced blister formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245507     DOI: 10.1111/1523-1747.ep12371697

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  The role of T cells in drug reaction.

Authors:  Andrea Cavani; Ornella De Pità
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.806

2.  Il-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactam antibiotics in immediate or delayed hypersensitivity reactions.

Authors:  I Gaspard; M T Guinnepain; J Laurent; N Bachot; S Kerdine; J Bertoglio; M Pallardy; H Lebrec
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.

Authors:  R S Kalish; J A Wood; A LaPorte
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 4.  Gene polymorphisms within the immune system that may underlie drug allergy.

Authors:  Rob J Vandebriel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

5.  Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Authors:  Paul Whitaker; Xiaoli Meng; Sidonie N Lavergne; Sabah El-Ghaiesh; Manal Monshi; Caroline Earnshaw; Daniel Peckham; Jimmy Gooi; Steve Conway; Munir Pirmohamed; Rosalind E Jenkins; Dean J Naisbitt; B Kevin Park
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

Review 6.  An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Authors:  Chun-Bing Chen; Riichiro Abe; Ren-You Pan; Chuang-Wei Wang; Shuen-Iu Hung; Yi-Giien Tsai; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

7.  Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis.

Authors:  Axel Patrice Villani; Aurore Rozieres; Benoît Bensaid; Klara Kristin Eriksson; Amandine Mosnier; Floriane Albert; Virginie Mutez; Océane Brassard; Tugba Baysal; Mathilde Tardieu; Omran Allatif; Floriane Fusil; Thibault Andrieu; Denis Jullien; Valérie Dubois; Catherine Giannoli; Henri Gruffat; Marc Pallardy; François-Loïc Cosset; Audrey Nosbaum; Osami Kanagawa; Janet L Maryanski; Daniel Yerly; Jean-François Nicolas; Marc Vocanson
Journal:  Sci Adv       Date:  2021-03-19       Impact factor: 14.136

8.  Immunologic evaluation of drug allergy.

Authors:  Enrique Gómez; Maria Jose Torres; Cristobalina Mayorga; Miguel Blanca
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-30       Impact factor: 5.764

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.